Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Advanced Biomedical Concept is a privately held Italian medical device company focused on surgical innovation in women’s health, particularly breast reconstruction. The company markets a portfolio of biomaterial membranes and related devices built around its Exashape technology, including Bioshield Pocket, Pocket 3D, Prepec, Grid, Expander, NAC, PRo, and the Exafat fat-grafting system. Its products are intended to improve implant coverage, tissue integration, remodeling, and surgical workflow in reconstructive breast procedures. The company also supports surgeon education, clinical studies, and international partner training as part of its commercialization strategy. Advanced Biomedical Concept appears to be a commercial-stage medtech business rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Advanced Bioconcept.